Emerging Applications in Drug Discovery & Development, Medical Imaging Analysis, Digital Twins, Synthetic Data, Electronic Health Record Management, and Virtual Assistants
The application of Generative AI (Gen AI) in healthcare is a rapidly growing field. In recent years, emerging applications in drug discovery and development, medical imaging analysis, digital twins, synthetic data, and electronic health records management, and virtual assistants have garnered significant interest thanks to their potential to revolutionize the field. This creates a promising opportunity for technology developers - such as software companies and startups - in the healthcare industry to center their R&D activities on these emerging technologies for their product development.
This report’s scope of analysis for emerging applications is multifaceted and involves considerations across technical, clinical decision support, safety, and economic domains. The primary focus of the study is to identify the emerging gap areas being adopted across the healthcare industry that will surpass conventional care methodologies.
With top-tier software companies positioning themselves as technology developers and Gen AI startups focusing on small but crucial aspects toward reducing the clinical burden and providing efficient clinical decision support systems and their collaborations, this study will delve into the potential benefits and outcomes, highlighting prospective and corresponding stakeholders in the competitive industry, and the evolution of generative AI across drugs, diagnostics, and treatment planning in the next five years.
Questions that this report answers:
- What are the growth drivers and restraints of Gen AI in healthcare?
- What are the types of models and benefits of Gen AI in drug discovery and development, medical imaging analysis, digital twins, synthetic data, electronic health record management, and virtual assistants?
- What are the key companies to action in the Gen AI healthcare industry?
- What are key collaborations and funding in the industry?
- What are the key Gen AI regulations?